Why Gilead Sciences Stock Is on the Move Today
Shares of the biotech heavyweight Gilead Sciences (NASDAQ: GILD) are poised for a strong showing today. In pre-market trading, the company's stock jumped by as much as 7.2% Friday morning.
The catalyst? Gilead's stock is trending higher today in response to the full approval of its coronavirus treatment Veklury (remdesivir) by the Food and Drug Administration for hospitalized patients age 12 or older. The drug was previously given emergency use authorization by the FDA for a portion of this same patient population back in May.
Source Fool.com
